| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
|
Leuk Res
|
2001
|
4.87
|
|
2
|
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
|
Eur J Clin Invest
|
2007
|
3.58
|
|
3
|
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
|
Clin Exp Allergy
|
2003
|
2.08
|
|
4
|
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
|
Blood
|
1992
|
1.49
|
|
5
|
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
|
J Clin Pathol
|
2004
|
1.43
|
|
6
|
Effects of dental amalgam and its components of histamine release from human basophils and tissue mast cells.
|
Wien Klin Wochenschr
|
1998
|
1.39
|
|
7
|
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.
|
Ann Oncol
|
2009
|
1.22
|
|
8
|
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.
|
J Clin Invest
|
1997
|
1.22
|
|
9
|
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
|
FASEB J
|
2001
|
1.21
|
|
10
|
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
|
Eur J Immunol
|
1999
|
1.17
|
|
11
|
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
|
Br J Haematol
|
2001
|
1.13
|
|
12
|
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells.
|
Eur J Clin Invest
|
2007
|
1.11
|
|
13
|
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes.
|
Immunology
|
1996
|
1.09
|
|
14
|
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
|
Eur J Clin Invest
|
2008
|
1.08
|
|
15
|
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
|
FASEB J
|
2001
|
1.08
|
|
16
|
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen.
|
J Immunol
|
1993
|
1.07
|
|
17
|
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergen.
|
J Immunol
|
2001
|
1.06
|
|
18
|
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
|
J Immunol
|
1995
|
1.05
|
|
19
|
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
|
J Immunol
|
2000
|
1.04
|
|
20
|
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
|
J Immunol
|
1993
|
1.03
|
|
21
|
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
|
Leukemia
|
2004
|
1.02
|
|
22
|
Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia.
|
Eur J Cancer
|
2011
|
1.00
|
|
23
|
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
|
Eur J Clin Invest
|
2008
|
0.99
|
|
24
|
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
|
Clin Exp Allergy
|
2004
|
0.98
|
|
25
|
Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
|
Leuk Res
|
2001
|
0.98
|
|
26
|
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
|
Eur J Clin Invest
|
2008
|
0.98
|
|
27
|
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
|
Ann Oncol
|
2008
|
0.98
|
|
28
|
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.
|
Leuk Res
|
2001
|
0.97
|
|
29
|
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
|
Hum Pathol
|
2001
|
0.96
|
|
30
|
Molecular characterization of dog albumin as a cross-reactive allergen.
|
J Allergy Clin Immunol
|
1994
|
0.96
|
|
31
|
Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen.
|
J Allergy Clin Immunol
|
1992
|
0.95
|
|
32
|
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy.
|
FASEB J
|
1999
|
0.95
|
|
33
|
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms.
|
Blood
|
2001
|
0.95
|
|
34
|
Identification of common allergenic structures in mugwort and ragweed pollen.
|
J Allergy Clin Immunol
|
1998
|
0.95
|
|
35
|
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
|
Eur J Clin Invest
|
2007
|
0.94
|
|
36
|
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
|
Leuk Res
|
2001
|
0.93
|
|
37
|
Immunoglobulin E response to human proteins in atopic patients.
|
J Invest Dermatol
|
1996
|
0.93
|
|
38
|
Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
|
J Immunol
|
1998
|
0.93
|
|
39
|
Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction.
|
J Biol Chem
|
1994
|
0.93
|
|
40
|
Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5).
|
J Allergy Clin Immunol
|
1996
|
0.93
|
|
41
|
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.
|
J Immunol
|
1999
|
0.92
|
|
42
|
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
|
Eur J Clin Invest
|
2004
|
0.92
|
|
43
|
Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations.
|
J Dent Res
|
1995
|
0.89
|
|
44
|
Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy.
|
Int J Immunopathol Pharmacol
|
2007
|
0.88
|
|
45
|
The surface membrane antigen phenotype of human blood basophils.
|
Allergy
|
1994
|
0.88
|
|
46
|
Metal ion-induced toxic histamine release from human basophils and mast cells.
|
J Biomed Mater Res
|
1998
|
0.88
|
|
47
|
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.
|
Allergy
|
2014
|
0.87
|
|
48
|
The immunoglobulin-like modules Cepsilon3 and alpha2 are the minimal units necessary for human IgE-FcepsilonRI interaction.
|
J Clin Invest
|
1999
|
0.86
|
|
49
|
Purification and characterization of recombinant Bet v I, the major birch pollen allergen. Immunological equivalence to natural Bet v I.
|
J Biol Chem
|
1993
|
0.86
|
|
50
|
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
|
Thromb Haemost
|
2002
|
0.86
|
|
51
|
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.
|
Curr Cancer Drug Targets
|
2012
|
0.86
|
|
52
|
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
|
Eur J Clin Invest
|
2008
|
0.86
|
|
53
|
Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin.
|
Gut
|
2000
|
0.85
|
|
54
|
Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.
|
Allergy
|
2006
|
0.85
|
|
55
|
Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
|
Eur J Clin Invest
|
2008
|
0.84
|
|
56
|
Variable expression of activation-linked surface antigens on human mast cells in health and disease.
|
Immunol Rev
|
2001
|
0.84
|
|
57
|
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.
|
Int Arch Allergy Immunol
|
1994
|
0.83
|
|
58
|
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus.
|
Lupus
|
2002
|
0.83
|
|
59
|
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7.
|
FASEB J
|
1999
|
0.83
|
|
60
|
Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2.
|
J Allergy Clin Immunol
|
1996
|
0.82
|
|
61
|
Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.
|
Leuk Lymphoma
|
1996
|
0.82
|
|
62
|
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.
|
Int J Immunopathol Pharmacol
|
2009
|
0.82
|
|
63
|
Characterization of LDL and VLDL binding sites on human basophils and mast cells.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.82
|
|
64
|
Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy.
|
Eur J Immunol
|
2002
|
0.81
|
|
65
|
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
|
J Allergy Clin Immunol
|
2001
|
0.81
|
|
66
|
Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques.
|
Tissue Antigens
|
1999
|
0.81
|
|
67
|
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease.
|
Allergy
|
2014
|
0.81
|
|
68
|
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit.
|
J Immunol Methods
|
1995
|
0.81
|
|
69
|
Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells.
|
Life Sci
|
1996
|
0.81
|
|
70
|
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
|
Eur J Clin Invest
|
2009
|
0.81
|
|
71
|
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes.
|
Eur J Clin Invest
|
2009
|
0.80
|
|
72
|
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
|
J Immunol
|
1998
|
0.80
|
|
73
|
Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand.
|
Circulation
|
1995
|
0.80
|
|
74
|
Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
|
Eur J Clin Invest
|
2003
|
0.80
|
|
75
|
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
|
Blood
|
1994
|
0.79
|
|
76
|
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
|
Wien Klin Wochenschr
|
1998
|
0.79
|
|
77
|
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
|
Leuk Res
|
2001
|
0.79
|
|
78
|
Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
|
Allergy
|
2005
|
0.79
|
|
79
|
Molecular and immunological characterization of a novel timothy grass (Phleum pratense) pollen allergen, Phl p 11.
|
Clin Exp Allergy
|
2002
|
0.79
|
|
80
|
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.
|
Int Arch Allergy Immunol
|
1997
|
0.79
|
|
81
|
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
|
Am J Hematol
|
1999
|
0.79
|
|
82
|
Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens.
|
J Allergy Clin Immunol
|
1993
|
0.78
|
|
83
|
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage.
|
Int J Clin Pharmacol Ther
|
2004
|
0.78
|
|
84
|
High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activity.
|
Biochem Biophys Res Commun
|
1996
|
0.77
|
|
85
|
High level expression of birch pollen profilin (Bet v 2) in Escherichia coli: purification and characterization of the recombinant allergen.
|
Biochem Biophys Res Commun
|
1995
|
0.77
|
|
86
|
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes.
|
Crit Rev Oncol Hematol
|
2010
|
0.77
|
|
87
|
Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
|
Int Arch Allergy Immunol
|
1999
|
0.77
|
|
88
|
Recombinant allergens. Steps on the way to diagnosis and therapy of type I allergy.
|
Adv Exp Med Biol
|
1996
|
0.76
|
|
89
|
Comorbidity, iron overload and HFE variants: a new prognostic complex in MDS?
|
Eur J Clin Invest
|
2009
|
0.75
|
|
90
|
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
|
Eur J Clin Invest
|
2001
|
0.75
|
|
91
|
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.
|
Ann Hematol
|
2000
|
0.75
|
|
92
|
[New concepts in therapy of type I allergic diseases].
|
Wien Klin Wochenschr
|
1993
|
0.75
|
|
93
|
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).
|
Ann Oncol
|
2007
|
0.75
|
|
94
|
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
|
Int Arch Allergy Immunol
|
1999
|
0.75
|
|
95
|
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
|
Ann Hematol
|
2003
|
0.75
|
|
96
|
Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
|
Histopathology
|
2006
|
0.75
|
|
97
|
Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
|
Ann Hematol
|
2013
|
0.75
|
|
98
|
Massive postoperative intramuscular bleeding in acquired von Willebrand's disease.
|
Ann Hematol
|
2002
|
0.75
|